Thioglycolic Acid

Thioglycolic Acid

SCHEMBL692043

O=C([O-])CS.O=C([O-])CS.[Mg+2]

nearest known ligand 0.47

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ATP4AATP4BGABBR1GABBR2HMGCR

The experimentally established mechanism targets of Thioglycolic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
CA4 P22748 6/20 0.47
CASP1 P29466 1/20 0.41
FFAR3 O14843 2/20 0.37
HDAC3 O15379 2/20 0.37
HDAC1 Q13547 2/20 0.37
HDAC2 Q92769 2/20 0.37
HDAC8 Q9BY41 2/20 0.37
TSHR P16473 1/20 0.35
HSD17B10 Q99714 1/20 0.35
CA1 P00915 3/20 0.33
CA2 P00918 1/20 0.33
FAHD1 Q6P587 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Thioglycolic Acid SCHEMBL2211463 1.00 CA4 (0.47) CA4CASP1FFAR3HDAC3HDAC1
Thioglycolic Acid SCHEMBL10895895 0.92 CA4 (0.53) CA4CASP1FFAR3HDAC3HDAC1
Thioglycolic Acid SCHEMBL16760982 0.92 CA4 (0.47) CA4CASP1FFAR3HDAC3HDAC1
Thioglycolic Acid SCHEMBL1275216 0.92 CA4 (0.47) CA4CASP1FFAR3HDAC3HDAC1
Thioglycolic Acid SCHEMBL216244 0.92 CA4 (0.47) CA4CASP1FFAR3HDAC3HDAC1
Thioglycolic Acid SCHEMBL156458 0.92 CA4 (0.47) CA4CASP1FFAR3HDAC3HDAC1
Thioglycolic Acid SCHEMBL59723 0.92
Thioglycolic Acid SCHEMBL8897741 0.92 CA4 (0.47) CA4CASP1FFAR3HDAC3HDAC1
Thioglycolic Acid SCHEMBL4274828 0.92
Thioglycolic Acid SCHEMBL10795892 0.92 CA4 (0.47) CA4CASP1FFAR3HDAC3HDAC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 526 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119050267-B Positive electrode capable of limiting lattice oxygen escape and preparation method and application thereof 华中科技大学 2026-05-12 CN claimed
CN-119410039-A Preparation method of multifunctional flame-retardant novel anti-skid pad 浙江佳洁塑胶有限公司 2025-02-11 CN claimed
CN-119050267-A Positive electrode capable of limiting lattice oxygen escape and preparation method and application thereof 华中科技大学 2024-11-29 CN claimed
CN-118299598-A S-Pt/N-NCP catalyst and preparation method thereof 南京动量材料科技有限公司 2024-07-05 CN claimed
US-20240173451-A1 FRAGRANCE COMPOSITIONS, METHODS OF MANUFACTURE THEREOF AND ARTICLES COMPRISING THE SAME Exuud, Inc. 2024-05-30 US claimed
CN-117729945-A Fragrance composition, method of making and articles comprising the same 埃克苏德公司 2024-03-19 CN claimed
EP-4294465-A1 FRAGRANCE COMPOSITIONS, METHODS OF MANUFACTURE THEREOF AND ARTICLES COMPRISING THE SAME Neerja Ventures, LLC (US) 2023-12-27 EP claimed
WO-2022192215-A1 FRAGRANCE COMPOSITIONS, METHODS OF MANUFACTURE THEREOF AND ARTICLES COMPRISING THE SAME NEERJA VENTURES, LLC (US) 2022-09-15 WO claimed
CN-113208937-A Cutin softening composition, preparation method and application thereof, external compound for treating onychomycosis, and preparation method and application thereof 中国医学科学院北京协和医院 2021-08-06 CN claimed
US-20210015777-A1 HEALING TOPICAL COMPOSITION FLORENGALE, LLC 2021-01-21 US claimed
EP-2442873-A2 METHODS AND COMPOUNDS FOR REDUCING ALLERGIC REACTIONS TO HAIR DYES Hds Limited (GB) 2012-04-25 EP claimed
WO-2012025435-A2 STABLE OXIDATIVE COLOURING COMPOSITION FOR KERATIN FIBRES KPSS-KAO PROFESSIONAL SALON SERVICES GMBH (DE) 2012-03-01 WO claimed
EP-2422762-A1 Stable oxidative colouring composition for keratin fibers KPSS-Kao Professional Salon Services GmbH (DE) 2012-02-29 EP claimed
US-20110300083-A1 PERSONAL CARE FORMULATIONS CONTAINING ALKYL KETAL ESTERS AND METHODS OF MANUFACTURE SEGETIS, INC. (US) 2011-12-08 US claimed
WO-2011143254-A2 PERSONAL CARE FORMULATIONS CONTAINING ALKYL KETAL ESTERS AND METHODS OF MANUFACTURE SEGETIS, INC. (US) 2011-11-17 WO claimed
WO-2010146142-A9 METHODS AND COMPOUNDS FOR REDUCING ALLERGIC REACTIONS TO HAIR DYES HDS LIMITED (GB) 2011-06-16 WO claimed
WO-2010146142-A2 METHODS AND COMPOUNDS FOR REDUCING ALLERGIC REACTIONS TO HAIR DYES HDS LIMITED (GB) 2010-12-23 WO claimed
US-20100189889-A1 Method for Treating the Surface of a Substrate Based on Sulphur Polymer, Intended to be Covered with a Coating ESSILOR INTERNATIONAL (COMPAGNIE GENERALE D'OPTIQUE) (FR) 2010-07-29 US claimed
WO-2000057845-A1 METHOD FOR REMOVAL OF HUMAN HORNY TISSUES JOHNSON AND JOHNSON CONSUMER COMPANIES, INC. (US) 2000-10-05 WO claimed
WO-1999049895-A2 METHOD FOR INCREASING THE PERMEABILITY OF HORNY HUMAN TISSUE JOHNSON AND JOHNSON CONSUMER COMPANIES, INC. (US) 1999-10-07 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110300083-A1 PERSONAL CARE FORMULATIONS CONTAINING ALKYL KETAL ESTERS AND METHODS OF MANUFACTURE KAT7, CUTA, KAT6B CA4 2810/4885CASP1 599/4885FFAR3 150/4885
US-20210015777-A1 HEALING TOPICAL COMPOSITION CUTA, CSDE1, SRI CA4 2478/4885CASP1 2633/4885FFAR3 4626/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.